The decision by the regional board will likely give ammunition to vaccine-sceptics and anti-vaxxers who pushed against the ...

The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the University of Oxford ...

“There is no question. COVID-19 is a deadly disease, and the Oxford-AstraZeneca vaccine can prevent it. It's also important to remember that COVID-19 itself can cause blood clots and low platelets.

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July. As AZ signed ...

Rwanda has been stepping up measures to combat Rift Valley Fever (RVF) following the country's second outbreak in two years, ...

In another similar report, the Kenya Pharmacy and Poisons Board (PPB) then announced that 279 people had suffered from adverse effects after taking the Oxford-AstraZeneca coronavirus vaccine.

Controversy followed close on the heels of a recent study on the long-term safety of Covaxin, the Covid-19 vaccine developed by Bharat Biotech in collaboration ...

The European Medicines Authority (EMA) will most likely not be able to approve the COVID-19 vaccine developed by drug maker AstraZeneca and the University of Oxford in January, the watchdog’s ...